These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

919 related articles for article (PubMed ID: 21740331)

  • 1. TGF-β signaling in fibrosis.
    Biernacka A; Dobaczewski M; Frangogiannis NG
    Growth Factors; 2011 Oct; 29(5):196-202. PubMed ID: 21740331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Connective tissue growth factor/CCN2-null mouse embryonic fibroblasts retain intact transforming growth factor-beta responsiveness.
    Mori Y; Hinchcliff M; Wu M; Warner-Blankenship M; M Lyons K; Varga J
    Exp Cell Res; 2008 Mar; 314(5):1094-104. PubMed ID: 18201696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment.
    Chen L; Yang T; Lu DW; Zhao H; Feng YL; Chen H; Chen DQ; Vaziri ND; Zhao YY
    Biomed Pharmacother; 2018 May; 101():670-681. PubMed ID: 29518614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Connective tissue growth factor expression after angiotensin II exposure is dependent on transforming growth factor-β signaling via the canonical Smad-dependent pathway in hypertensive induced myocardial fibrosis.
    Wong CKS; Falkenham A; Myers T; Légaré JF
    J Renin Angiotensin Aldosterone Syst; 2018; 19(1):1470320318759358. PubMed ID: 29575960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte growth factor suppresses renal interstitial myofibroblast activation and intercepts Smad signal transduction.
    Yang J; Dai C; Liu Y
    Am J Pathol; 2003 Aug; 163(2):621-32. PubMed ID: 12875981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of renal fibrotic genes by TGF-β1 requires EGFR activation, p53 and reactive oxygen species.
    Samarakoon R; Dobberfuhl AD; Cooley C; Overstreet JM; Patel S; Goldschmeding R; Meldrum KK; Higgins PJ
    Cell Signal; 2013 Nov; 25(11):2198-209. PubMed ID: 23872073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profibrotic up-regulation of glucose transporter 1 by TGF-β involves activation of MEK and mammalian target of rapamycin complex 2 pathways.
    Andrianifahanana M; Hernandez DM; Yin X; Kang JH; Jung MY; Wang Y; Yi ES; Roden AC; Limper AH; Leof EB
    FASEB J; 2016 Nov; 30(11):3733-3744. PubMed ID: 27480571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-β orchestrates fibrogenic and developmental EMTs via the RAS effector RREB1.
    Su J; Morgani SM; David CJ; Wang Q; Er EE; Huang YH; Basnet H; Zou Y; Shu W; Soni RK; Hendrickson RC; Hadjantonakis AK; Massagué J
    Nature; 2020 Jan; 577(7791):566-571. PubMed ID: 31915377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma.
    Ghosh AK; Bhattacharyya S; Lakos G; Chen SJ; Mori Y; Varga J
    Arthritis Rheum; 2004 Apr; 50(4):1305-18. PubMed ID: 15077315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autocrine TGF-beta signaling in the pathogenesis of systemic sclerosis.
    Ihn H
    J Dermatol Sci; 2008 Feb; 49(2):103-13. PubMed ID: 17628443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Long Noncoding RNA DNM3OS Is a Reservoir of FibromiRs with Major Functions in Lung Fibroblast Response to TGF-β and Pulmonary Fibrosis.
    Savary G; Dewaeles E; Diazzi S; Buscot M; Nottet N; Fassy J; Courcot E; Henaoui IS; Lemaire J; Martis N; Van der Hauwaert C; Pons N; Magnone V; Leroy S; Hofman V; Plantier L; Lebrigand K; Paquet A; Lino Cardenas CL; Vassaux G; Hofman P; Günther A; Crestani B; Wallaert B; Rezzonico R; Brousseau T; Glowacki F; Bellusci S; Perrais M; Broly F; Barbry P; Marquette CH; Cauffiez C; Mari B; Pottier N
    Am J Respir Crit Care Med; 2019 Jul; 200(2):184-198. PubMed ID: 30964696
    [No Abstract]   [Full Text] [Related]  

  • 12. TGF-β-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases.
    Pardali E; Sanchez-Duffhues G; Gomez-Puerto MC; Ten Dijke P
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29039786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-β signaling in the kidney: profibrotic and protective effects.
    Sureshbabu A; Muhsin SA; Choi ME
    Am J Physiol Renal Physiol; 2016 Apr; 310(7):F596-F606. PubMed ID: 26739888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of TGF-β/Smad signaling by the small compound HPH-15 ameliorates experimental skin fibrosis.
    Luong VH; Chino T; Oyama N; Matsushita T; Sasaki Y; Ogura D; Niwa SI; Biswas T; Hamasaki A; Fujita M; Okamoto Y; Otsuka M; Ihn H; Hasegawa M
    Arthritis Res Ther; 2018 Mar; 20(1):46. PubMed ID: 29544542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.
    Mori Y; Ishida W; Bhattacharyya S; Li Y; Platanias LC; Varga J
    Arthritis Rheum; 2004 Dec; 50(12):4008-21. PubMed ID: 15593186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-β in tissue fibrosis.
    Frangogiannis N
    J Exp Med; 2020 Mar; 217(3):e20190103. PubMed ID: 32997468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crosstalk between the TGF-β and WNT signalling pathways during cardiac fibrogenesis.
    Działo E; Tkacz K; Błyszczuk P
    Acta Biochim Pol; 2018; 65(3):341-349. PubMed ID: 30040870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-beta signaling in vascular fibrosis.
    Ruiz-Ortega M; Rodríguez-Vita J; Sanchez-Lopez E; Carvajal G; Egido J
    Cardiovasc Res; 2007 May; 74(2):196-206. PubMed ID: 17376414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted disruption of TGF-beta/Smad3 signaling modulates skin fibrosis in a mouse model of scleroderma.
    Lakos G; Takagawa S; Chen SJ; Ferreira AM; Han G; Masuda K; Wang XJ; DiPietro LA; Varga J
    Am J Pathol; 2004 Jul; 165(1):203-17. PubMed ID: 15215176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A20 suppresses canonical Smad-dependent fibroblast activation: novel function for an endogenous inflammatory modulator.
    Bhattacharyya S; Wang W; Graham LV; Varga J
    Arthritis Res Ther; 2016 Oct; 18(1):216. PubMed ID: 27716397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.